4
Changes in Ownership
Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-004098
Chief Scientific Officer sold 582,023 shares at $2.08 ($1,213,402)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mor George Adi Chief Scientific Officer | 2022-11-16 | Sale | −324,775 | $2.08 | $677,091 | 324,775 | D: show line 1 in the form |
| Mor George Adi Chief Scientific Officer | 2022-11-16 | Sale | −257,248 | $2.08 | $536,311 | 257,247 | I: show line 2 in the form |
| Open-market sales · 582,023 sh · avg $2.08 · $1,213,402 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mor George Adi Chief Scientific Officer | 2018-03-15 | Grant or award · Option to Purchase American Depositary Shares | +131,698 | 131,698 | D: show line 3 in the form | ||
| Mor George Adi Chief Scientific Officer | 2016-10-28 | Grant or award · Option to Purchase American Depositary Shares | +33,725 | 33,725 | I: show line 4 in the form |
Loading xslF345X03/ownership.xml…